Will Pharmaceutical ETFs Continue To Rally This Holiday Season? (PJP)

pills-drugs-biotech2
From Zacks: As we head toward the end of 2017, the pharma sector continues to perform well, representing a contrast to 2016 when the sector was under immense pressure due to the drug pricing issue.
NYSE:PJP November 8, 2017 6:11am

It Might Be Time To Buy Pharmaceuticals (PJP)

white-pills
From Invesco: The pharmaceutical industry has lagged in recent years, due in part to political uncertainty, which has kept a lid on company share prices.
NYSE:PJP July 6, 2017 6:18am

Pharmaceuticals (PJP) Won’t Be The Only Sector Hurt By Legal Pot

medical-marijuana
From Bill Hall: In my most recent Money and Markets articles, I’ve put you on the inside track about a rapidly growing, yet mostly still under-the-radar, industry. One that the world’s super-rich are quietly funding with their own money, in pursuit of potentially eye-popping investment returns.
NYSE:PJP June 19, 2017 6:12am

Time To Buy Pharmaceutical ETFs?

Image of multicolor pills in blister pack
From Zacks: 2016 turned out to be a challenging year for pharma stocks with the sector facing a lot of criticism for rising drug prices. Although the election results provided a breather for the sector on hopes that drug pricing would not be a key focus area under a Donald Trump presidency, the relief rally turned out to be short-lived with the President clarifying his stand on rising drug prices.
NYSE:PJP March 16, 2017 7:32am

Pharma ETFs In Focus As Washington Debates Prescription Drug Pricing

white-pills
With all of the talk from Capitol Hill in regards to prescription pill prices and proposed healthcare reform, today we hone in on the Pharmaceutical segment within the greater Healthcare industry sector in ETF land.
NYSE:PJP March 2, 2017 12:00pm

Trump’s War On Drug Prices Not The Only Concern For Pharma Companies

Image of multicolor pills in blister pack
From Brad Hoppmann: The news out of Washington keeps flooding out, and specifically news that’s being made straight from the Oval Office.
NYSE:PJP February 1, 2017 7:26am

Are Pharmaceutical Stocks In Trouble?

biotech-medical-pillsFrom Dana Lyons: The post-2009 bull market in drug stocks is currently being threatened, with a key index reaching a critical technical level.
NYSE:PJP September 20, 2016 8:54am

ETFs To Watch On Solid Pharma Earnings [Market Vectors Pharmaceutical ETF, iShares Dow Jones US Pharm Indx (ETF)]

healthcare3The healthcare space has emerged relatively unscathed from the biotech meltdown seen early in the year and is clearly outperforming the broad market. This is primarily thanks to strong performances by both biotech and pharma companies
NYSE:IHE October 31, 2014 3:32pm

A Beaten-Up Pharma With a Big Upside [The Medicines Company(NASDAQ:MDCO), Pfizer Inc.(NYSE:PFE), Merck & Co., Inc.(NYSE:MRK)]

biotechnologyThe Medicines Company(NASDAQ:MDCO) has had a really tough first half of 2014, and the stock price shows it. When one of its drugs did not receive approval from regulators and a court decision concerning one of its drugs going generic went against the company, the stock dropped
NYSE:IHE August 19, 2014 10:15am

ETF Impact On Biotech Earnings [Celgene Corporation, Alexion Pharmaceuticals, Inc., Amgen, Inc., Biogen Idec Inc]

biotechnologyThe Q2 earnings season has so far been great for biotech companies with most of them giving solid quarterly updates. Biotech giant Gilead Sciences (GILD) continued with its exceptional performance in this quarter as well, beating the Zacks Consensus Estimate
NASDAQ:BIB July 31, 2014 4:23pm

ETFs To Watch On Strong Earnings From Pharma Companies [Pfizer Inc., Merck & Co., Inc., Eli Lilly and Co]

healthcare1The pharma space has been seeing smooth trading thanks to encouraging industry trends such as development of new drugs, the rising wave of mergers and acquisitions, increased need for medical services, expansion into emerging markets
NYSE:IHE July 30, 2014 5:10pm

ETFs To Cash In On Aging Global Population [SPDR KBW Capital Markets (ETF), Vanguard Dividend Appreciation ETF]

etfs etfsNeena Mishra: Global population is growing older at an unprecedented rate. The number of persons aged 60 years or more worldwide is expected to increase from 841 million in 2013 to more than 2 billion by 2050 and their share will almost double
NYSE:KCE June 27, 2014 11:35am

ETFs To Watch As Obamacare Hits Deadline [PowerShares Dynamic Pharmaceuticals(ETF), SPDR S&P Biotech (ETF)]

healthcare-etfsDespite the rocky start and a plethora of technical issues, the Affordable Care Act (often known as Obamacare) saw a surge in enrollment in the final days of its first year program. More than 6 million Americans (as of March 27) have signed
NYSE:FXH March 31, 2014 5:09pm

Top Pharmaceutical ETFs To Consider [Biogen Idec Inc, SPDR S&P Pharmaceuticals (ETF), Health Care SPDR (ETF)]

healthcare1After the incredible surge in 2013, the healthcare sector is no doubt crushing the overall market this year too. This is largely thanks to the bullish trend in both the pharma and biotech segments
NYSE:IHE March 16, 2014 4:04pm

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular


From Our Partners


Explore More from ETFDailyNews.com

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again!

ETFDailyNews.com respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories